Filter
752
Filtered Results: 752
Text search:
antigènes
Featured
Recommendations
79
New Publications
168
Language
Document type
No document type
366
Guidelines
190
Studies & Reports
88
Manuals
43
Strategic & Response Plan
20
Fact sheets
20
Situation Updates
9
Training Material
8
Brochures
3
Infographics
3
Videos
2
Countries / Regions
India
41
Latin America and the Carribbean
29
Brazil
29
Germany
27
Global
25
Argentina
17
Kenya
16
Africa
15
Western and Central Europe
14
Uganda
14
Colombia
12
Paraguay
12
Tanzania
11
Bolivia
11
Nigeria
10
East and Southern Africa
10
South Africa
10
Liberia
9
Nepal
8
Rwanda
8
Ethiopia
8
El Salvador
7
Sierra Leone
7
Malawi
7
Philippines
7
West and Central Africa
7
Chile
6
Peru
6
Mozambique
6
Myanmar / Burma
6
Venezuela
5
Bangladesh
5
Ecuador
5
Lesotho
4
Zimbabwe
4
Middle East and North Africa
4
South–East Asia Region
4
Ukraine
3
Ghana
3
Cameroon
3
USA
3
Cambodia
3
Congo, Democratic Republic of
3
Namibia
3
Angola
3
Botswana
3
Zambia
3
North America
2
Spain
2
Eastern Europe
2
South Sudan
2
Indonesia
2
Somalia
2
Pakistan
2
Guatemala
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Syria
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Dominican Republic
1
Western Pacific Region
1
United Kingdom
1
Portugal
1
Nicaragua
1
Sri Lanka
1
Russia
1
Sudan
1
Honduras
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
326
Clinical Guidelines
107
Pharmacy & Technologies
32
Public Health
29
Women & Child Health
19
Key Resources
7
Capacity Building
3
Toolboxes
COVID-19
130
TB
101
NTDs
66
HIV
48
Rapid Response
33
Mental Health
21
Refugee
16
Ebola
11
Pharmacy
11
Polio
11
Planetary Health
8
Caregiver
7
NCDs
6
Zika
5
AMR
5
Natural Hazards
4
Cholera
4
Conflict
3
Disability
2
Global Health Education
2
Specific Hazards
1
Health Financing Toolbox
1
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and ...
